Trexquant Investment LP Cuts Position in The Cooper Companies, Inc. (NASDAQ:COO)

Trexquant Investment LP trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 28.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 164,353 shares of the medical device company’s stock after selling 65,236 shares during the period. Trexquant Investment LP’s holdings in Cooper Companies were worth $15,109,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of COO. Byrne Asset Management LLC purchased a new stake in Cooper Companies during the fourth quarter valued at $33,000. OFI Invest Asset Management bought a new stake in shares of Cooper Companies in the 4th quarter worth about $34,000. New Age Alpha Advisors LLC purchased a new stake in shares of Cooper Companies during the 4th quarter valued at about $38,000. West Financial Advisors LLC bought a new position in shares of Cooper Companies in the 4th quarter valued at about $49,000. Finally, Atala Financial Inc purchased a new position in Cooper Companies in the fourth quarter worth about $51,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $81.27 on Wednesday. The company has a 50 day simple moving average of $88.87 and a two-hundred day simple moving average of $96.83. The stock has a market cap of $16.25 billion, a price-to-earnings ratio of 41.68, a PEG ratio of 2.25 and a beta of 1.02. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 12 month low of $77.05 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

COO has been the subject of several analyst reports. Robert W. Baird lowered their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a research note on Friday, March 7th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Piper Sandler reiterated an “overweight” rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus lowered their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. Finally, StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.